Search research articles
Contact Us
Filters
Showing results (51-60 of 82) with videos related to
Page
of 9
Sort By:
Science Signaling
|
April 17, 2014
Intronic miR-3151 within BAALC drives leukemogenesis by deregulating the TP53 pathway
Ann-Kathrin Eisfeld, Sebastian Schwind, Ravi Patel, et al.
Cancer
|
March 4, 2023
Circulating tumor DNA-based molecular residual disease detection for treatment monitoring in advanced melanoma patients
Zeynep Eroglu, Shifra Krinshpun, Ekaterina Kalashnikova, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
February 12, 2022
Immunodepletion of MDSC by AMV564, a novel bivalent, bispecific CD33/CD3 T cell engager, ex vivo in MDS and melanoma
Pingyan Cheng, Xianghong Chen, Robert Dalton, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 10, 2009
A multi-institutional phase II study of the efficacy and tolerability of lapatinib in patients with advanced hepatocellular carcinomas
Tanios Bekaii-Saab, Joseph Markowitz, Nichole Prescott, et al.
Scientific Reports
|
November 15, 2017
Nitric oxide mediated inhibition of antigen presentation from DCs to CD4<sup>+</sup> T cells in cancer and measurement of STAT1 nitration
Joseph Markowitz, Jiang Wang, Zach Vangundy, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
May 6, 2024
Patient reported outcomes and patient experiences of immune checkpoint modulators for advanced or recurrent melanoma: a mixed methods study
Danielle B Tometich, Carley Geiss, Melinda L Maconi, et al.
Scientific Reports
|
March 8, 2018
Author Correction: Nitric oxide mediated inhibition of antigen presentation from DCs to CD4<sup>+</sup> T cells in cancer and measurement of STAT1 nitration
Joseph Markowitz, Jiang Wang, Zach Vangundy, et al.
Frontiers in Immunology
|
March 13, 2020
Multi-Dimensional Flow Cytometry Analyses Reveal a Dichotomous Role for Nitric Oxide in Melanoma Patients Receiving Immunotherapy
Saurabh K Garg, Matthew J Ott, A G M Mostofa, et al.
Biopolymers
|
May 20, 2014
Simultaneous inhibition of key growth pathways in melanoma cells and tumor regression by a designed bidentate constrained helical peptide
Amlanjyoti Dhar, Shampa Mallick, Piya Ghosh, et al.
Frontiers in Oncology
|
March 20, 2018
Combination of Ipilimumab and Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes for Patients with Metastatic Melanoma
John E Mullinax, MacLean Hall, Sangeetha Prabhakaran, et al.
Page
of 9
Search research articles
Search
Showing results (51-60 of 82) with videos related to
Sort By:
Page
of 9
Science Signaling
|
April 17, 2014
Intronic miR-3151 within BAALC drives leukemogenesis by deregulating the TP53 pathway
Ann-Kathrin Eisfeld, Sebastian Schwind, Ravi Patel, et al.
Cancer
|
March 4, 2023
Circulating tumor DNA-based molecular residual disease detection for treatment monitoring in advanced melanoma patients
Zeynep Eroglu, Shifra Krinshpun, Ekaterina Kalashnikova, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
February 12, 2022
Immunodepletion of MDSC by AMV564, a novel bivalent, bispecific CD33/CD3 T cell engager, ex vivo in MDS and melanoma
Pingyan Cheng, Xianghong Chen, Robert Dalton, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 10, 2009
A multi-institutional phase II study of the efficacy and tolerability of lapatinib in patients with advanced hepatocellular carcinomas
Tanios Bekaii-Saab, Joseph Markowitz, Nichole Prescott, et al.
Scientific Reports
|
November 15, 2017
Nitric oxide mediated inhibition of antigen presentation from DCs to CD4<sup>+</sup> T cells in cancer and measurement of STAT1 nitration
Joseph Markowitz, Jiang Wang, Zach Vangundy, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
May 6, 2024
Patient reported outcomes and patient experiences of immune checkpoint modulators for advanced or recurrent melanoma: a mixed methods study
Danielle B Tometich, Carley Geiss, Melinda L Maconi, et al.
Scientific Reports
|
March 8, 2018
Author Correction: Nitric oxide mediated inhibition of antigen presentation from DCs to CD4<sup>+</sup> T cells in cancer and measurement of STAT1 nitration
Joseph Markowitz, Jiang Wang, Zach Vangundy, et al.
Frontiers in Immunology
|
March 13, 2020
Multi-Dimensional Flow Cytometry Analyses Reveal a Dichotomous Role for Nitric Oxide in Melanoma Patients Receiving Immunotherapy
Saurabh K Garg, Matthew J Ott, A G M Mostofa, et al.
Biopolymers
|
May 20, 2014
Simultaneous inhibition of key growth pathways in melanoma cells and tumor regression by a designed bidentate constrained helical peptide
Amlanjyoti Dhar, Shampa Mallick, Piya Ghosh, et al.
Frontiers in Oncology
|
March 20, 2018
Combination of Ipilimumab and Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes for Patients with Metastatic Melanoma
John E Mullinax, MacLean Hall, Sangeetha Prabhakaran, et al.
Page
of 9